Advancements in Psychoactive Alkaloid Delivery, Neuroenhancement, and Psychedelic Therapies: Exploring the Frontiers of Modern Pharmacology
ACS Medicinal Chemistry Letters May 8, 2024 DOI: 10.1021/acsmedchemlett.4c00181 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psilocybin Psychedelic-assisted therapy |
| Keywords | Transdermal Pharmacology Neurostimulation Tryptamine Hallucinogen |
| Citations | 2 |
| Key findings | Innovations in transdermal formulations, neuroenhancement, intravenous infusion of psilocybin or psilocin, and crystalline tryptamine derivatives represent significant progress in drug delivery systems and therapeutic use of psychedelic compounds. |
Abstract
This Patent Highlight explores advancements in pharmacology, focusing on the novel delivery and application of psychoactive substances. It highlights the development of transdermal formulations for psychoactive alkaloids, neuroenhancement techniques to augment emotional responses, and the intravenous infusion of psilocybin or psilocin for various therapeutic purposes. Additionally, it delves into the characterization and potential uses of crystalline forms of tryptamine derivatives. These innovations signify significant progress in drug delivery systems, neurostimulation methods, and the therapeutic use of psychedelic compounds, potentially revolutionizing the treatment of psychological and neurological disorders.